CD7

Creative Biolabs is dedicated to providing top-quality anti-CD7 antibodies to support the vital work of researchers in the biomedical field. We recognize the crucial role that targeted antibodies play in advancing scientific discovery, and our products are meticulously designed to meet the highest standards of quality and reliability. With a commitment to excellence, we aim to empower researchers by supplying the tools they need to achieve impactful results in their studies.

CD7: A Cell Surface Antigen in Cancer Disease

CD7 is a cell surface antigen expressed on T cells and natural killer cells. As a target for research, it holds significant importance. In the field of immunology, studying CD7 helps in understanding the development and function of these immune cells. It can provide insights into immune responses and disorders related to T cells and NK cells. In cancer research, CD7 is often a target for immunotherapies as it is overexpressed in certain types of leukemia and lymphomas. Targeting CD7 may offer new treatment strategies for these malignancies. Additionally, understanding CD7 can aid in the development of diagnostic tools and therapies for various immune-mediated diseases.

Alternative Names

CD7 molecule; GP40; TP41; Tp40; LEU-9

Background

CD7 is a transmembrane protein that is a member of the immunoglobulin superfamily. CD7 is found on thymocytes and mature T cells. CD7 plays an essential role in T-cell interactions and also in T-cell/B-cell interaction during early lymphoid development.

Anti-CD7 rAb Products

We are committed to providing high-quality anti-CD7 recombinant antibody products with the aim of accelerating research and discovery in the field of target-related drugs.

Creative Quality Control

Our team is dedicated to ensuring that the antibody products are of the highest quality, meticulously crafted through advanced technologies and rigorous quality control processes. By offering these top-notch antibodies, we hope to contribute to the advancement of scientific research and the development of more effective drugs targeting CD7.

Customer Reviews

Excellent

Lu**y
Recombinant Human Anti-human CD7 Antibody Fab Fragment (Cat#: MHH-183-F(E))

In my study focused on hematological malignancies, I used the human anti-human CD7 antibody Fab fragment. Detection was carried out using WB and neutralization assays. WB offered precise visualization of the target protein, while the neutralization assays showcased its potential in modulating disease-related pathways. The antibody fragment was crucial for my research, facilitating my exploration and yielding significant results.

7/May/2022

Excellent

Si*o
Recombinant Camel Anti-CD7 Single Domain Antibody (Cat#: HPAB-0265-YJ-VHH)

I employed the camel anti-CD7 single domain antibody in my research on immune cell characteristics. Using the recommended dilution and concentration ratio, I obtained excellent results. FC enabled clear identification and quantification of cells expressing CD7, providing valuable information about cell populations. IF offered detailed visualization of the localization of CD7 within cells, enhancing my understanding of its functional role.

20/Sep/2022

rAb Production

We have accumulated many years of experience in optimizing processes related to expression vectors, screening transfected cell lines, and purifying antibodies. We provide top-notch services spanning from gene synthesis to antibody production for those in the field of biomedical research.

Featured Anti-CD7 Recombinant Antibody Production Platforms
Fig.3 Milligram-scale recombinant antibody production.

Fig.4 Gram-scale recombinant antibody production

rAb Modalities

Creative Biolabs strives to offer multiple forms of the recombinant antibody. Whether it's for basic research, drug discovery, or any other scientific pursuit, our antibodies are designed to meet the unique needs of our customers and contribute to the advancement of scientific knowledge.

Fig.5 Full Length Anti-CD7 Recombinant Antibody Production and Modalities

Drug Information Targeting CD7

Table 1. Therapeutic approaches targeting CD7 in clinical development.

If you would like to know more about our anti-CD7 recombinant antibody products or have any questions, please feel free to contact us at any time. Our dedicated team is here to provide comprehensive support and serve you wholeheartedly, ensuring all your research needs are met.